Intersect ENT, Inc. Insider Trading for February 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Intersect ENT, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Intersect ENT, Inc. for February 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Option Exercise | A | 26.18 | 13,250 | 346,885 | 13,250 | |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 6,690 | 0 | 31,086 | 24.4 K to 31.1 K (+27.42 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | CARSCADDEN GWEN R. | Chief People Office ... | Grant | A | 0.00 | 6,690 | 0 | 24,396 | 17.7 K to 24.4 K (+37.78 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Option Exercise | A | 26.18 | 19,250 | 503,965 | 19,250 | |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Grant | A | 0.00 | 9,720 | 0 | 27,035 | 17.3 K to 27 K (+56.14 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Kowalski Christine R | Chief Operating Off ... | Grant | A | 0.00 | 9,720 | 0 | 17,315 | 7.6 K to 17.3 K (+127.98 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Option Exercise | A | 26.18 | 21,870 | 572,557 | 21,870 | |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Grant | A | 0.00 | 11,040 | 0 | 38,332 | 27.3 K to 38.3 K (+40.45 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Binney Robert H Jr | Chief Commercial Of ... | Grant | A | 0.00 | 11,040 | 0 | 27,292 | 16.3 K to 27.3 K (+67.93 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Option Exercise | A | 26.18 | 21,270 | 556,849 | 21,270 | |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Grant | A | 0.00 | 10,740 | 0 | 79,205 | 68.5 K to 79.2 K (+15.69 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | Lehman David Aaron | EVP & General Couns ... | Grant | A | 0.00 | 10,740 | 0 | 68,465 | 57.7 K to 68.5 K (+18.61 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Option Exercise | A | 26.18 | 78,700 | 2,060,366 | 78,700 | |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 39,700 | 0 | 217,855 | 178.2 K to 217.9 K (+22.28 %) |
| Feb 05 2020 | XENT | Intersect ENT, Inc ... | West Thomas A. | President and CEO | Grant | A | 0.00 | 39,700 | 0 | 178,155 | 138.5 K to 178.2 K (+28.67 %) |